Publicaciones en colaboración con investigadores/as de David Geffen School of Medicine at UCLA (13)

2023

  1. Astrocytes in human central nervous system diseases: a frontier for new therapies

    Signal Transduction and Targeted Therapy, Vol. 8, Núm. 1

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Reactive astrocyte nomenclature, definitions, and future directions

    Nature Neuroscience, Vol. 24, Núm. 3, pp. 312-325

2020

  1. CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease

    Nature Communications, Vol. 11, Núm. 1

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

2015

  1. Neuroinflammation in Alzheimer's disease

    The Lancet Neurology, Vol. 14, Núm. 4, pp. 388-405

2014

  1. Glia in the pathogenesis of neurodegenerative diseases

    Biochemical Society Transactions, Vol. 42, Núm. 5, pp. 1291-1301

2012

  1. In vivo veritas, in vitro artificia

    Trends in Molecular Medicine

  2. Neurological diseases as primary gliopathies: A reassessment of neurocentrism

    ASN Neuro, Vol. 4, Núm. 3, pp. 131-149

2010

  1. An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness

    Immunity, Vol. 33, Núm. 6, pp. 929-941

  2. LIM-homeobox gene Lhx5 is required for normal development of Cajal-Retzius cells

    Journal of Neuroscience, Vol. 30, Núm. 31, pp. 10551-10562

  3. Regulatory T cells in obesity: the leptin connection

    Trends in Molecular Medicine, Vol. 16, Núm. 6, pp. 247-256

2006

  1. Circulating insulin-like growth factor I and functional recovery from spinal cord injury under enriched housing conditions

    European Journal of Neuroscience, Vol. 23, Núm. 4, pp. 1035-1046